Inhibition of SGLT1 abrogates preconditioning-induced cardioprotection against ischemia-reperfusion injury
- 1 April 2016
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 472 (2), 392-398
- https://doi.org/10.1016/j.bbrc.2016.02.016
Abstract
No abstract availableFunding Information
- Department of Biotechnology (BT/PR13768/MED/30/300/2010)
- Ramalingaswami Fellowship Funds (BT/HRD/35/02/2006)
This publication has 17 references indexed in Scilit:
- Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3The Journal of Nutritional Biochemistry, 2015
- Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injuryJournal of Molecular and Cellular Cardiology, 2014
- AMPK-Regulated and Akt-Dependent Enhancement of Glucose Uptake Is Essential in Ischemic Preconditioning-Alleviated Reperfusion InjuryPLOS ONE, 2013
- Development of a cell-based nonradioactive glucose uptake assay system for SGLT1 and SGLT2Analytical Biochemistry, 2012
- SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathyJournal of Molecular and Cellular Cardiology, 2010
- Ischemic Postconditioning Inhibits Apoptosis aft er Acute Myocardial Infarction in PigsThe Heart Surgery Forum, 2010
- Protein kinase‐A affects sorting and conformation of the sodium‐dependent glucose co‐transporter SGLT1Journal of Cellular Biochemistry, 2008
- Ischemia‐reperfusion and cardioprotection: A delicate balance between reactive oxygen species generation and redox homeostasisAnnals of Medicine, 2007
- Insulin resistance, abnormal energy metabolism and increased ischemic damage in the chronically infarcted rat heartCardiovascular Research, 2006
- Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.Circulation, 1986